Cargando…

Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy

Arrhythmogenic cardiomyopathy (ACM) is a heritable heart muscle disease characterized by syncope, palpitations, ventricular arrhythmias and sudden cardiac death (SCD) especially in young individuals. It is estimated to affect 1:5,000 individuals in the general population, with >60% of patients be...

Descripción completa

Detalles Bibliográficos
Autores principales: Bueno-Beti, Carlos, Asimaki, Angeliki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688541/
https://www.ncbi.nlm.nih.gov/pubmed/34950711
http://dx.doi.org/10.3389/fcvm.2021.746321
_version_ 1784618375399342080
author Bueno-Beti, Carlos
Asimaki, Angeliki
author_facet Bueno-Beti, Carlos
Asimaki, Angeliki
author_sort Bueno-Beti, Carlos
collection PubMed
description Arrhythmogenic cardiomyopathy (ACM) is a heritable heart muscle disease characterized by syncope, palpitations, ventricular arrhythmias and sudden cardiac death (SCD) especially in young individuals. It is estimated to affect 1:5,000 individuals in the general population, with >60% of patients bearing one or more mutations in genes coding for desmosomal proteins. Desmosomes are intercellular adhesion junctions, which in cardiac myocytes reside within the intercalated disks (IDs), the areas of mechanical and electrical cell-cell coupling. Histologically, ACM is characterized by fibrofatty replacement of cardiac myocytes predominantly in the right ventricular free wall though left ventricular and biventricular forms have also been described. The disease is characterized by age-related progression, vast phenotypic manifestation and incomplete penetrance, making proband diagnosis and risk stratification of family members particularly challenging. Key protein redistribution at the IDs may represent a specific diagnostic marker but its applicability is still limited by the need for a myocardial sample. Specific markers of ACM in surrogate tissues, such as the blood and the buccal epithelium, may represent a non-invasive, safe and inexpensive alternative for diagnosis and cascade screening. In this review, we shall cover the most relevant biomarkers so far reported and discuss their potential impact on the diagnosis, prognosis and management of ACM.
format Online
Article
Text
id pubmed-8688541
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86885412021-12-22 Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy Bueno-Beti, Carlos Asimaki, Angeliki Front Cardiovasc Med Cardiovascular Medicine Arrhythmogenic cardiomyopathy (ACM) is a heritable heart muscle disease characterized by syncope, palpitations, ventricular arrhythmias and sudden cardiac death (SCD) especially in young individuals. It is estimated to affect 1:5,000 individuals in the general population, with >60% of patients bearing one or more mutations in genes coding for desmosomal proteins. Desmosomes are intercellular adhesion junctions, which in cardiac myocytes reside within the intercalated disks (IDs), the areas of mechanical and electrical cell-cell coupling. Histologically, ACM is characterized by fibrofatty replacement of cardiac myocytes predominantly in the right ventricular free wall though left ventricular and biventricular forms have also been described. The disease is characterized by age-related progression, vast phenotypic manifestation and incomplete penetrance, making proband diagnosis and risk stratification of family members particularly challenging. Key protein redistribution at the IDs may represent a specific diagnostic marker but its applicability is still limited by the need for a myocardial sample. Specific markers of ACM in surrogate tissues, such as the blood and the buccal epithelium, may represent a non-invasive, safe and inexpensive alternative for diagnosis and cascade screening. In this review, we shall cover the most relevant biomarkers so far reported and discuss their potential impact on the diagnosis, prognosis and management of ACM. Frontiers Media S.A. 2021-12-07 /pmc/articles/PMC8688541/ /pubmed/34950711 http://dx.doi.org/10.3389/fcvm.2021.746321 Text en Copyright © 2021 Bueno-Beti and Asimaki. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Bueno-Beti, Carlos
Asimaki, Angeliki
Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
title Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
title_full Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
title_fullStr Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
title_full_unstemmed Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
title_short Histopathological Features and Protein Markers of Arrhythmogenic Cardiomyopathy
title_sort histopathological features and protein markers of arrhythmogenic cardiomyopathy
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688541/
https://www.ncbi.nlm.nih.gov/pubmed/34950711
http://dx.doi.org/10.3389/fcvm.2021.746321
work_keys_str_mv AT buenobeticarlos histopathologicalfeaturesandproteinmarkersofarrhythmogeniccardiomyopathy
AT asimakiangeliki histopathologicalfeaturesandproteinmarkersofarrhythmogeniccardiomyopathy